[1]
Kumar, D. et al. 2026. Efficacy And Safety Of Sodium-Glucose Cotransporter-2 (Sglt2) And Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Combination Therapy In Patients With Type 2 Diabetes Inadequately Controlled By Metformin. Pakistan Armed Forces Medical Journal. 76, 2 (Apr. 2026), 279–286. DOI:https://doi.org/10.51253/pafmj.v76i2.12228.